BNET Industries
Chiron Corp. is in the Pharma Industry
Latest News and Analysis
Research and Markets: A Fourth Division for Novartis under the Title Vaccines & Diagnostics, Will Be Created After the Acquisition of Chiron Corporation
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c41412) has announced the addition of Espicom Business Intelligence's Novartis Prospects to 2010 to their offering.
Stocks to Watch Friday: CHIR, NSTK, IRIX, INGN.
M2 PRESSWIRE-17 March 2006-RumorAlerts.com: Stocks to Watch Friday: CHIR, NSTK, IRIX, INGNC1994-2006 M2 COMMUNICATIONS LTD RDATE:17032006 Sarasota, FL - RumorAlerts.com Stocks to Watch on Friday, March 17, 2006: Chiron Corporation (Nasdaq: CHIR), Nastech Pharmaceutical Company, Inc. (Nasdaq: NSTK), Iridex Corporation (Nasdaq:...
ViroPharma Licenses Rights to Develop Novel Therapeutic for Treatment of Clostridium Difficile-Associated Disease and Chiron Receives British Vaccine Contract.
M2 PRESSWIRE-28 February 2006-US Financial Network: ViroPharma Licenses Rights to Develop Novel Therapeutic for Treatment of Clostridium Difficile-Associated Disease and Chiron Receives British Vaccine ContractC1994-2006 M2 COMMUNICATIONS LTD RDATE:28022006 City of Industry, CA - Biotechnology industry news provided by Financial...
Chiron to supply United States with pandemic influenza vaccine for stockpile; Contract with U.S. Department of Health & Human Services for H5N1 stockpile.
M2 PRESSWIRE-28 October 2005-Chiron Corporation: Chiron to supply United States with pandemic influenza vaccine for stockpile; Contract with U.S. Department of Health & Human Services for H5N1 stockpileC1994-2005 M2 COMMUNICATIONS LTD RDATE:27102005 Chiron Corporation (NASDAQ:CHIR) today announced that it has won...
Chiron to Supply United States with Pandemic Influenza Vaccine for Stockpile and Invitrogen Announces Third Quarter 2005 Results.
M2 PRESSWIRE-28 October 2005-US Financial Network: Chiron to Supply United States with Pandemic Influenza Vaccine for Stockpile and Invitrogen Announces Third Quarter 2005 ResultsC1994-2005 M2 COMMUNICATIONS LTD RDATE:28102005 City of Industry, CA - Biotechnology industry news provided by Financial News...
Chiron to Supply United States with Pandemic Influenza Vaccine for Stockpile; Contract with U.S. Department of Health & Human Services for H5N1 Stockpile
EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR) today announced that it has won a $62.5 million contract to supply the U.S. government with pre-pandemic influenza vaccine for a stockpile to protect against the H5N1 avian influenza virus strain. Under the agreement with the Department of Health and Human Services HHS, Chiron...
Chiron Initiates U.S. Phase I/II Study of Influenza Cell Culture Vaccine
EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR)
Chiron to Hold Conference Call on Flu Vaccines on Monday, October 17; Company Will Discuss the Return of FLUVIRIN® Influenza Virus Vaccine and the Future Prospects of Its Influenza Vaccine Business
EMERYVILLE, Calif. -- Chiron Corporation (Nasdaq:CHIR) today announced that it will hold an investor conference call on Monday, October 17, at 4:30 p.m. EDT to discuss the return of its FLUVIRINR influenza virus vaccine to the U.S. market and the company's influenza vaccines business outlook.
Flu vaccines will be late, cost more this year.(Brief Article)
The Centers for Disease Control and Prevention won't give the OK to distribute the vaccine broadly until after Oct. 24. Before that time, only high-risk individuals should get the vaccine. The reason: The CDC figures that supplies will be adequate bu The Centers for Disease Control...
Chiron Cancels Begrivac Vaccine Supply and Nabi Biopharmaceuticals Announces Completion of NicVAX(TM) Phase II Clinical Trial Enrollment.
M2 PRESSWIRE-20 July 2005-US Financial Network: Chiron Cancels Begrivac Vaccine Supply and Nabi Biopharmaceuticals Announces Completion of NicVAXTM Phase II Clinical Trial EnrollmentC1994-2005 M2 COMMUNICATIONS LTD RDATE:20072005 City of Industry, CA - Biotechnology industry news provided by Financial News USA...
Chiron Will Not Supply BEGRIVAC™ Influenza Virus Vaccine to Non-U.S. Markets for the 2005-2006 Influenza Season; Company is Working to Cover BEGRIVAC Vaccine Shortfall with Other Non-U.S. Influenza Vaccines
EMERYVILLE, Calif. -- No Change to Financial Guidance
Forbes Medi-Tech Receives European Approval to Market Reducol and Chiron Jumps as U.K. Lifts Vaccine Ban.
M2 PRESSWIRE-3 March 2005-FNWU: Forbes Medi-Tech Receives European Approval to Market Reducol and Chiron Jumps as U.K. Lifts Vaccine BanC1994-2005 M2 COMMUNICATIONS LTD RDATE:03032005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Forbes Medi-Tech...
Chiron FLUVIRIN Vaccine License Reinstated by UK Regulatory Agency
EMERYVILLE, Calif. -- MHRA Will Monitor Ongoing Remediation Progress; Chiron Expects Full FDA cGMP Inspection
Chiron Appoints Jack Goldstein President and Chief Operating Officer; Gene Walther Appointed President of Chiron Blood Testing; Daniel Soland Appointed President of Chiron Vaccines
EMERYVILLE, Calif. -- Chiron Corporation (Nasdaq:CHIR) today announced the appointment of Jack Goldstein, 57, to the position of president and chief operating officer. Dr. Goldstein has served in this capacity on an interim basis since November 2004 and previously served as president of Chiron Blood Testing.
Chiron Announces Change in Status of SEC Inquiry
EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR) announced today that the U.S. Securities and Exchange Commission SEC has issued a formal order of investigation with respect to potential violations of federal securities laws. The previously announced informal inquiry began following the suspension by the UK Medicines and Healthcare products Regulatory Agency...
Chiron's vaccine plant hit with longer suspension.
By Paul Jacobs, San Jose Mercury News, Calif. Knight Ridder/Tribune Business News By Paul Jacobs, San Jose Mercury News, Calif. Knight Ridder/Tribune Business News
MHRA Notifies Chiron of Continuing Suspension of Liverpool License for Influenza Vaccines; Suspension May Be Lifted If Compliance with License Demonstrated
EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR) today announced that it has received notice from the UK Medicines and Healthcare Products Regulatory Agency MHRA that the MHRA proposes to continue the suspension of the company's license to manufacture influenza vaccines in Liverpool for a further period of three months, effective January...
Bacteria afflicted Chiron's vaccine plant, documents reveal.
By Paul Jacobs, San Jose Mercury News, Calif. Knight Ridder/Tribune Business News By Paul Jacobs, San Jose Mercury News, Calif. Knight Ridder/Tribune Business News
Shortage shakes flu bug fight; Area hospitals hope for shot at receiving more vaccines.(Insight)
Byline: SHANNON MORTLAND As the flu season begins, health organizations everywhere are scrambling to come up with more of the scarcely available flu vaccine. They likely won't find it in Northeast Ohio. Though some local hospitals received their Byline: SHANNON MORTLAND...
Chiron Responds to FDA Announcement; Company Committed to Taking Appropriate Action to Return to Market as Reliable Supplier of Influenza Vaccine
EMERYVILLE, Calif. -- Chiron Corporation (Nasdaq:CHIR) provided the following statement in response to the announcement by U.S. health officials today.
- Next »
- page 1 of 3
- « Previous
Sort byClose
View Related Content by Tag Close
Industry Transcripts by Seeking Alpha
-
Indevus Pharmaceuticals, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about IDEV
-
Noven Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about NOVN
-
XenoPort, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about XNPT
-
Repligen Corporation F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 24, 2008about RGEN
-
Omrix Biopharmaceuticals, Inc. Q3 2008 Earnings Call Transcript
on Nov 24, 2008about OMRI
Chiron Corp. Company Info
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
